Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELASOMERAN Cause Wrong technique in product usage process? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Wrong technique in product usage process have been filed in association with ELASOMERAN. This represents 0.8% of all adverse event reports for ELASOMERAN.

16
Reports of Wrong technique in product usage process with ELASOMERAN
0.8%
of all ELASOMERAN reports
0
Deaths
8
Hospitalizations

How Dangerous Is Wrong technique in product usage process From ELASOMERAN?

Of the 16 reports, 8 (50.0%) required hospitalization, and 2 (12.5%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELASOMERAN. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does ELASOMERAN Cause?

Fatigue (317) Covid-19 (294) Pyrexia (231) Headache (216) Pain (209) Arthralgia (163) Malaise (152) Pain in extremity (152) Nausea (149) Drug ineffective (132)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which ELASOMERAN Alternatives Have Lower Wrong technique in product usage process Risk?

ELASOMERAN vs ELBASVIR ELASOMERAN vs ELBASVIR\GRAZOPREVIR ELASOMERAN vs ELDECALCITOL ELASOMERAN vs ELECTROLYTES NOS ELASOMERAN vs ELECTROLYTES NOS\MINERALS

Related Pages

ELASOMERAN Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process ELASOMERAN Demographics